BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240226
DTEND;VALUE=DATE:20240229
DTSTAMP:20260516T003938
CREATED:20240213T102528Z
LAST-MODIFIED:20240213T102742Z
UID:38686-1708905600-1709164799@www.pharmajournalist.com
SUMMARY:3rd Next-Generation Conjugates Summit
DESCRIPTION:From Bristol Myers Squibb expanding their cardiovascular partnership with Avidity Biosciences’ antibody-oligonucleotide conjugate technology\, to Nurix and Seagen collaborating on a targeted protein degradation conjugate\, there is now a staggering amount of investment and collaboration in the novel conjugates space. \nAs highlighted above\, drug developers are pushing the boundaries of traditional ADCs by designing and developing novel targeting formats and payloads. Whilst the likes of VincerX Pharma\, Dyne Therapeuitcs and Alnylam are now awaiting clinical validation\, and others continue to innovate in conjugate design\, it is an exciting time for the next-generation conjugates field. \n \nCovering case-study led presentations on novel design concepts\, key translational and clinical development challenges\, and addressing challenging CMC roadblocks\, the Next-Generation Conjugates Summit is your only event uniting developers of a wide array of novel formats and payloads\, with conjugate modality types including antibody-oligonucleotide conjugates\, fragment-drug conjugates\, Targeted Radiopharmaceutical Conjugates\, small molecule-drug conjugates\, bispecific-drug conjugates and more! \nThis is the only event to unite 100+ drug developers from companies of different modality types that would not normally come together\, so make sure to join likeminded conjugate developers to learn\, collaborate and innovate and expand on the potential of conjugate drugs. \nLearn more here: https://ter.li/q5wf9x
URL:http://www.pharmajournalist.com/event/3rd-next-generation-conjugates-summit/
LOCATION:Hotel Commonwealth\, 500 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:adc@hansonwade.com
END:VEVENT
END:VCALENDAR